Regulatory and government disclosure obligations increasingly require companies to submit highly sensitive technical and commercial information that would otherwise qualify as trade secrets. Join this session to find out how in-house teams manage regulatory compliance without undermining future trade secret protection or litigation position.

• Understand where US regulatory disclosures most commonly weaken trade secret claims, including FDA filings, cybersecurity reporting, and other mandatory submissions.
• Learn how FOIA and government access risks are assessed in practice, and what courts look for when companies argue information remained confidential after disclosure.
• Identify procurement and government contracting disclosures that can compromise trade secret protection, and how to mitigate those risks upfront.
• Take away practical strategies for structuring regulatory submissions to preserve trade secret status and support reasonable-measures arguments in future disputes.

2026 marks the tenth anniversary of the enactment of the Defend Trade Secrets Act (DTSA), a landmark act that has brought previously unseen legal recognition and protection of trade secrets within the US. This keynote session will reflect on the progress made over the past ten years, key court decisions that continue to change the direction of trade secret legal protection, and predictions on how trade secret legal protection may continue to evolve.